Artiva biotherapeutics to participate in the 2024 cantor fitzgerald global healthcare conference

San diego, sept. 10, 2024 (globe newswire) -- artiva biotherapeutics, inc. (nasdaq: artv), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced that management will participate in a fireside chat at the 2024 cantor fitzgerald global healthcare conference on wednesday, september 18, 2024, at 8:00 a.m.
ARTV Ratings Summary
ARTV Quant Ranking